RESULTS
There were 81 responses with a survey response rate of 27%. The
majority, 63%, of responders were generalist, followed by providers who
identified themselves as MFM 33%. The majority of providers worked at
an academic center 54%, followed by those who practiced in a
hospital-based setting 30%, and then private practice 21%. The
majority of responders had been in practice > 20 years
72%, followed by physicians who had been in practice 3-5 years 10%
(Table 1). TXA was mostly used during PPH 72%, followed by heavy cyclic
bleeding 42%, and was least used in benign surgeries 5% such as
myomectomy and hysterectomy (Figure 1a). The most common use of TXA was
during PPH, however the most selected frequency 33% of use by
respondents was < 10% (Figure 1b).
Results show that when the hospital had TXA as part of its PPH protocol,
86% of providers used TXA for PPH. When TXA was not part of the
hospitals PPH or the providers did not know if TXA was part of the
hospital’s protocol 60% of providers at those hospitals did not use TXA
(Table 2). When asked how comfortable providers would be at
incorporating TXA into their hospitals protocol, and overwhelming number
95% said very or somewhat comfortable (Figure 2).
The main concern physicians had with TXA was thromboembolic events,
48%, followed by lack of familiarity 23% and that they prefer other
agents for bleeding 24%. 33% of responders had no concerns with using
TXA. Other concerns included cost 18% and risk of hypersensitivity
reaction to medication 4% (Figure 3).